Affilin™ molecules: Novel ligands for bioseparation

Food and Bioproducts Processing

Volumn 84, Issue 1 C, 2006, Pages 3-8

  Fiedler, E ^a   Fiedler, M ^a   Proetzel, G ^a   Scheuermann, T ^a   Fiedler, U ^a   Rudolph, R ^b  

^a Scil Proteins GmbH   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Affilin ; Affinity chromatography; Bioseparation; ProNGF; B crystallin

Indexed keywords

AFFINITY CHROMATOGRAPHY; BIOCHEMISTRY; CHARACTERIZATION; MOLECULES; PROTEINS; PURIFICATION; SEPARATION; SURFACE PLASMON RESONANCE;

AFFINITY PURIFICATION; BIOSEPARATION; BIOTHERAPEUTICS; LIGANDS; PROTEIN PURIFICATION;

BIOTECHNOLOGY;

ESCHERICHIA COLI;

EID: 33646581375     PISSN: 09603085     EISSN: None     Source Type: Journal    
DOI: 10.1205/fbp.05222     Document Type: Article

References (20)

1. BIAapplications Handbook, 1998, BIAcore AB, Uppsala, Sweden.
2. Burgess, R.R. and Thompson, N.E., 2002, Advances in gentle immunoaffinity chromatography, Curr Opin Biotechnol, 13(4): 304-308.
3. De Lano, W.L., 2002, The Pymol Molecular Graphics System (DeLano Scientific LLC, San Carlo, CA).
4. Ebersbach, H., Fiedler, E., Scheuermann, T., Fiedler, M., Stubbs, M.T., Reimann, C., Proetzel, G., Rudolph, R. and Fiedler, U., 2006, Affilin™-novel binding molecules based on human γ-B-crystallin, an all β-sheet protein, in preparation.
5. FDA Guidance for Industry, 2001, Monoclonal antibodies used as reagent in drug manufacturing, http://www.fda.gov/cder/guidance/3630fnl.pdf.
6. Fiedler, U. and Rudolph, R., 2001, Fabrication of beta-pleated sheet proteins with specific binding properties, International patent application WO 01/04144.
7. Hage, D.S., 1999, Affinity chromatography: A review of clinical applications, Clin Chem, 45: 593-615.
8. Hardy, E., Martinez, E., Diago, D., Diaz, R., Gonzalez, D. and Herrera, L., 2000, Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris, J Biotechnol, 77: 157-167.
9. Hey, T., Fiedler, E., Rudolph, R. and Fiedler, M., 2005, Artificial, non-antibody binding proteins for pharmaceutical and industrial applications, Trends in Biotechnol, 23(10): 514-522.
10. Jaenicke, R., 1994, Eye-lens proteins: structure, superstructure, stability, genetics, Naturwissenschaften, 81: 423-429.
11. Jaenicke, R., 1996, Stability and folding of ultrastable proteins: eye lens crystallins and enzymes from thermophiles, Faseb J, 10: 84-92.
12. Jaenicke, R. and Slingsby, C., 2001, Lens crystallins and their microbial homologs: structure, stability, and function, Crit Rev Biochem Mol Biol, 36: 435-499.
13. Kay, B.K., Winter, J. and McCafferty, J., 1996, Phage Display of Peptides and Proteins: A Laboratory Manual (Academic, San Diego).
14. Nygren, P.A. and Skerra, A., 2004, Binding proteins from alternative scaffolds, J Immunol Methods, 290: 3-28.
15. Rattenholl, A., Lilie, H., Grossmann, A., Stern, A., Schwarz, E. and Rudolph, R., 2001, The pro-sequence facilitates folding of human nerve growth factor from Escherichia coli inclusion bodies. Eur J Biochem 268: 3296-3303.
16. Rudolph, R., Siebendritt, R., Nesslauer, G., Sharma, A.K. and Jaenicke, R., 1990, Folding of an all-beta protein: independent domain folding in gamma II-crystallin from calf eye lens, Proc Natl Acad Sci, 87: 4625-4629.
17. Secher, D.S. and Burke, D.C., 1980, A monoclonal antibody for large-scale purification of human leukocyte interferon, Nature, 285(5765): 446-450.
18. Sharma, A.K., Minke-Gogl, V., Gohl, P., Siebendritt, R., Jaenicke, R. and Rudolph, R., 1990, Limited proteolysis of gamma II-crystallin from calf eye lens. Physicochemical studies on the N-terminal domain and the intact two-domain protein, Eur J Biochem, 194: 603-609.
19. Skerra, A., 2003, Imitating the humoral immune response, Curr Opin Chem Biol, 7: 683-693.
20. Subramanian, A., 2002, Immunoaffinity chromatography, Mol Biotechnol, 20: 41-47.